JPH10313857A - Kinase - Google Patents

Kinase

Info

Publication number
JPH10313857A
JPH10313857A JP12377497A JP12377497A JPH10313857A JP H10313857 A JPH10313857 A JP H10313857A JP 12377497 A JP12377497 A JP 12377497A JP 12377497 A JP12377497 A JP 12377497A JP H10313857 A JPH10313857 A JP H10313857A
Authority
JP
Japan
Prior art keywords
adp
anhydroglucitol
substrate
nucleoside
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12377497A
Other languages
Japanese (ja)
Other versions
JP4001658B2 (en
Inventor
Shinji Koga
晋治 古賀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP12377497A priority Critical patent/JP4001658B2/en
Publication of JPH10313857A publication Critical patent/JPH10313857A/en
Application granted granted Critical
Publication of JP4001658B2 publication Critical patent/JP4001658B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a new kinase, having high substrate specificity for 1,5- anhydroglucitol (1,5-AG), capable of phosphorylating the 1,5-AG in the presence of nucleoside diphosphates and Mg ions and useful for the measurement, etc., of the 1,5-AG with a high accuracy. SOLUTION: This new ADP-dependent hexokinase has higher substrate specificity for 1,5-anhydroglucitol (1,5-AG) than that in the case of using glucose as a substrate, is capable of catalyzing a reaction for substituting hydroxyl group at the 6-position of the 1,5-AG with phosphate group in the presence of nucleoside diphosphates and magnesium ions and producing 1,5-anhydroglucitol phosphate and nucleoside monphosphates, is used for simply measuring the 1,5-AG with a high accuracy and is useful for diagnosis, etc., of diabetes by measuring the amount of the 1,5-AG in blood plasma. The enzyme is obtained by culturing a strain of Thermococcus litoralis ATCC51850 in a culture medium at 95 deg.C for 20 hr, then separating and crushing the microbial cell and extracting and purifying an active fraction from the resultant crushed liquid of the microbial cell.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、ヌクレオシドジリ
ン酸類およびマグネシウムイオン存在下1,5アンヒド
ログルシトール(以下、1,5AGと略す)の6位の水
酸基をリン酸基に置換し1,5アンヒドログルシトール
6リン酸(以下、1,5AG6Pと略す)とヌクレオシ
ドモノリン酸を生成する反応を触媒し、かつ1,5AG
に対して高い基質特異性を有する新規なADP依存性ヘ
キソキナーゼに関し、診断用酵素分野に関する。
TECHNICAL FIELD The present invention relates to a method for substituting 1,6-anhydroglucitol (hereinafter abbreviated as 1,5AG) at the 6-position hydroxyl group with a phosphate group in the presence of nucleoside diphosphates and magnesium ions. Catalyzes a reaction for producing 5-anhydroglucitol hexaphosphate (hereinafter abbreviated as 1,5AG6P) and nucleoside monophosphate, and comprises 1,5AG
Novel ADP-dependent hexokinase having high substrate specificity for the enzyme and the field of diagnostic enzymes.

【0002】[0002]

【従来技術】1,5AGはヒト髄液、血漿、血清、尿中
などに存在し、ある種の疾患、特に糖尿病において血漿
中の量が低下することが報告されている化合物であり
(日本内科学会会誌80巻、1198−1204、19
91)、近年、糖尿病診断マーカーとして使用されてい
る物質である。
2. Description of the Related Art 1,5AG is a compound which is present in human cerebrospinal fluid, plasma, serum, urine and the like, and has been reported to decrease the amount in certain diseases, especially in diabetes (Japanese Internal Medicine). Journal of the Society of Japan 80, 1198-1204, 19
91), a substance that has recently been used as a diagnostic marker for diabetes.

【0003】従来、生体試料中の1,5AGを測定する
方法としてはガスクロマトグラフィー法(糖尿病、25
巻、1115−1118、1982)、ピラノースオキ
シダーゼを用いて測定する方法(特開昭63−1853
97号公報)、グルコキナーゼまたはヘキソキナーゼを
用いて測定する方法(特開平8−107796号公報)
などが知られていた。
Conventionally, as a method for measuring 1,5AG in a biological sample, gas chromatography (diabetes, 25
Vol. 11, 115-1118, 1982) and a method of measuring using pyranose oxidase (JP-A-63-1853).
No. 97), a method of measuring using glucokinase or hexokinase (JP-A-8-107796).
Etc. were known.

【0004】しかしながら、ガスクロマトグラフィー法
は被検液の前処理として1,5AGのラベル化が必要で
ある上、測定に長時間を要し、多数の検体を同時に測定
することが困難であり、しかも分析機器の維持、管理に
高度の技術を必要とするなどの欠点があり、実際の臨床
に応用するには不便であった。またピラノースオキシダ
ーゼを用いた1,5AGの測定法はピラノースオキシダ
ーゼが基質としてピラノース類に広く作用するため1,
5AGを正確に測定することができなかった。
[0004] However, the gas chromatography method requires labeling of 1,5AG as a pretreatment of a test solution, and requires a long time for measurement, and it is difficult to measure a large number of samples simultaneously. In addition, there are drawbacks such as the need for advanced technology for maintenance and management of analytical instruments, and it is inconvenient to apply it to actual clinical practice. In addition, the method for measuring 1,5AG using pyranose oxidase is based on the fact that pyranose oxidase acts widely on pyranoses as a substrate.
5AG could not be measured accurately.

【0005】さらにATPをリン酸供与体として1,5
AGをリン酸化する酵素としてヘキソキナーゼ、グルコ
キナーゼが知られていたがヘキソキナーゼおよびグルコ
キナーゼがグルコースに対して高い特異性を示し、1,
5AGに対してほとんど作用せず、現実的に1,5−A
Gの測定は不可能であった。
Further, ATP is used as a phosphate donor for 1,5
Hexokinase and glucokinase were known as enzymes that phosphorylate AG, but hexokinase and glucokinase show high specificity for glucose.
Has almost no effect on 5AG, and practically 1,5-A
Measurement of G was not possible.

【0006】[0006]

【発明が解決しようとする課題】本発明は1,5AGに
対して高い特異性を持ち、同時に液状試薬として長期保
存安定性を有する新規な酵素を提供することを目的とす
る。
SUMMARY OF THE INVENTION An object of the present invention is to provide a novel enzyme having a high specificity for 1,5AG and, at the same time, having a long-term storage stability as a liquid reagent.

【0007】[0007]

【課題を解決するための手段】まず、本発明者らは1,
5AGに対して特異的に作用する酵素を広く微生物から
スクリーニングしたところ、超高度好熱菌サーモコッカ
ス・リトラリス・ATCC51850菌株の菌体内にヌ
クレオシドジリン酸類の1種であるADPの存在下1,
5AGをリン酸化して1,5AG6Pを生成する反応を
触媒するADP依存性ヘキソキナーゼ(以下、ADP−
HKと略す)を初めて見出し、特に基質としてグルコー
スを用いるに比べて1,5AGに高い基質特異性を有す
ることを見出した。
Means for Solving the Problems First, the present inventors have set forth 1,
When a wide variety of enzymes that specifically act on 5AG were screened from microorganisms, it was found that ADP, which is a kind of nucleoside diphosphates, was present in the cells of the ultra-high thermophilic bacterium Thermococcus litoralis ATCC 51850.
ADP-dependent hexokinase that catalyzes the reaction that phosphorylates 5AG to generate 1,5AG6P (hereinafter ADP-
HK) for the first time, and in particular, it has been found that 1,5AG has a higher substrate specificity than using glucose as a substrate.

【0008】本発明は上記の知見に基づいて完成された
もので、基質としてグルコースを用いるに比べて1,5
AGに対して高い基質特異性を有し、ヌクレオシドジリ
ン酸類およびマグネシウムイオン存在下、1,5AGの
6位の水酸基をリン酸基に置換し、1,5AG6Pとヌ
クレオシドモノリン酸類を生成する反応を触媒するAD
P−HKに関するものである。
The present invention has been completed on the basis of the above findings, and is 1,5 times smaller than when glucose is used as a substrate.
It has high substrate specificity for AG, and catalyzes the reaction of generating 1,5AG6P and nucleoside monophosphates by substituting the hydroxyl group at the 6-position of 1,5AG with a phosphate group in the presence of nucleoside diphosphates and magnesium ions. AD
It concerns P-HK.

【0009】まず、本発明ADP−HKの取得方法を述
べる。本発明のグルコースを用いるに比べて1,5AG
に対して高い基質特異性を有するADP−HKは基質と
して1,5AGに対して高い基質特異性を有する酵素で
あれば何ら限定されるものではなく、例えば超高度好熱
菌サーモコッカス・リトラリス・ATCC51850菌
株由来のADP−HKが挙げられる。超高度好熱菌サー
モコッカス・リトラリス・ATCC51850菌株はア
メリカン・タイプ・カルチャー・コレクション(ATC
C)に寄託され、ATCCカタログ(19th、199
6年)に記載されており、何人も入手可能である。
First, a method for obtaining ADP-HK of the present invention will be described. 1,5AG compared to using the glucose of the present invention
ADP-HK having high substrate specificity is not limited as long as it is an enzyme having high substrate specificity to 1,5AG as a substrate. For example, ADP-HK is a thermophilic bacterium Thermococcus litoralis. ADP-HK derived from ATCC 51850 strain. The hyperthermophilic bacterium Thermococcus litoralis ATCC 51850 is from the American Type Culture Collection (ATC).
C) and the ATCC catalog (19th, 199th)
6 years) and is available to many.

【0010】ADP−HK生産菌の培養方法は例えば後
述に記載する実施例と同様の培地を用いて通気すること
なく培養すればよく、培養温度は菌の生育する温度範囲
で行えばよく、70〜110℃、好ましくは85〜10
5℃である。また、培養時間は目的とする酵素が最高力
価となる培養時間、例えば1〜3日にて目的とする酵素
を採取すればよい。
ADP-HK-producing bacteria can be cultured, for example, by using the same medium as in the examples described later without aeration, and the culture temperature may be within the temperature range in which the bacteria grow. ~ 110 ° C, preferably 85 ~ 10
5 ° C. The culture time may be the culture time at which the target enzyme has the highest titer, for example, 1 to 3 days, and the target enzyme may be collected.

【0011】ADP−HKは主としてその菌体内に含
有、蓄積されており、その菌体内から抽出すればよい。
ADP−HKの抽出法を例示すれば培養液から菌体を遠
心分離などによって分離し、菌体をリン酸緩衝液、トリ
ス塩酸緩衝液などの緩衝液に懸濁した後、リゾチーム、
超音波、ガラスビーズなどによって破砕して遠心分離
し、可溶性画分を粗酵素液として回収する。
ADP-HK is mainly contained and accumulated in the cells, and may be extracted from the cells.
For example, the extraction method of ADP-HK is to separate cells from the culture solution by centrifugation or the like, suspend the cells in a buffer such as a phosphate buffer or a Tris-HCl buffer, and then add lysozyme,
The mixture is crushed by ultrasonic waves, glass beads, etc., and centrifuged, and the soluble fraction is recovered as a crude enzyme solution.

【0012】このようにして得られた粗製のADP−H
K含有液を公知の蛋白質、酵素の単離、精製手段を用い
て処理することにより、精製されたADP−HKを得る
ことができる。例えばアセトンまたはエタノールなどの
有機溶媒による分別沈殿法、硫酸アンモニウムなどによ
る塩析法、イオン交換クロマトグラフィー法、疎水クロ
マトグラフィー法、アフィニティークロマトグラフィー
法、ゲルろ過法などの一般的な酵素精製法を適宜選択、
組み合わせて精製ADP−HKを得ることができ、適宜
安定化剤例えばショ糖、グリセロールなどを5〜50%
程度、アミノ酸、補酵素などを0.01〜0.1%程度
加えて凍結保存または凍結乾燥させてもよい。
The crude ADP-H thus obtained
The purified ADP-HK can be obtained by treating the K-containing solution using known protein and enzyme isolation and purification means. For example, a general enzyme purification method such as a fractional precipitation method using an organic solvent such as acetone or ethanol, a salting out method using ammonium sulfate, an ion exchange chromatography method, a hydrophobic chromatography method, an affinity chromatography method, and a gel filtration method is appropriately selected. ,
Purified ADP-HK can be obtained in combination with 5 to 50% of a suitable stabilizer such as sucrose, glycerol or the like.
Alternatively, amino acids, coenzymes, and the like may be added in an amount of about 0.01 to 0.1%, and may be cryopreserved or lyophilized.

【0013】次に、ADP−HKの1,5AGを基質と
したときの反応メカニズムはエッシェリヒア・コリDH
1(ATCC33849)株の菌体内に存在する1,5
アンヒドログルシトール6リン酸デヒドロゲナーゼ
(1,5AG6PDH)を用いて検討した。この1,5
AGを基質としたときのADP−HKの反応は、下記反
応式
Next, the reaction mechanism when 1,5AG of ADP-HK is used as a substrate is Escherichia coli DH
1,5 present in the cells of strain 1 (ATCC 33849)
It examined using anhydroglucitol 6-phosphate dehydrogenase (1,5AG6PDH). These 1,5
The reaction of ADP-HK using AG as a substrate is represented by the following reaction formula.

【0014】[0014]

【化2】 Embedded image

【0015】にて表される。また、1,5AG6PDH
は、少なくとも下記反応式を触媒する酵素である。
## EQU1 ## Also, 1,5AG6PDH
Is an enzyme that catalyzes at least the following reaction formula.

【0016】[0016]

【化3】 Embedded image

【0017】で示される。1,5AG6PDHとしては
1,5AG6Pを基質とし、例えば補酵素として酸化型
ニコチンアミドアデニンジヌクレオチド(リン酸)〔酸
化型NAD(P):NAD(P)+ 〕を消費して還元型
ニコチンアミドアデニンジヌクレオチド(リン酸)〔還
元型NAD(P):NAD(P)H+H+ 〕を生成する
1,5AG6PDHであればなんら限定されるものでは
ない。
## EQU1 ## 1,5AG6PDH uses 1,5AG6P as a substrate, and consumes oxidized nicotinamide adenine dinucleotide (phosphate) [oxidized NAD (P): NAD (P) + ] as a coenzyme to reduce nicotinamide adenine. There is no particular limitation as long as it is 1,5AG6PDH that produces dinucleotide (phosphate) [reduced NAD (P): NAD (P) H + H + ].

【0018】またこの1,5AG6PDH生産菌として
はエシェリヒア属に属する1,5AG6PDH生産菌で
あれば何ら限定されるものではなく,1,5AG6PD
Hを生産する能力を有するその変異株であってもよい。
好ましくはエシェリヒア・コリ属に属する生産菌が考え
られ、より好ましいものとしてエシェリヒア・コリ・D
H1(ATCC33849)はATCCに保存され、A
TCC(18th、1992年)カタログに記載されて
おり、何人も入手可能であり本菌株から得られた1,5
AG6PDHが好ましい。
The 1,5AG6PDH producing bacterium is not limited as long as it is a 1,5AG6PDH producing bacterium belonging to the genus Escherichia.
The mutant having the ability to produce H may be used.
Preferably, a production bacterium belonging to the genus Escherichia coli is considered, and more preferably, Escherichia coli D.
H1 (ATCC 33849) is stored in the ATCC,
It is described in the catalog of TCC (18th, 1992), and is available to many people.
AG6PDH is preferred.

【0019】次いで1,5AG6PDHを得るに当たっ
て好ましくはエシェリヒア・コリ・DH1(ATCC3
3849)を培養するものでこの培養手段としては固体
培養でも液体培養でもよいが好ましくはフラスコ、ジャ
ー等による通気培養である。この培地としては微生物の
培養に通常用いられるものが広く使用される。炭素源と
してグルコース、グリセロール、ソルビトール、ラクト
ースなど、窒素源としては酵母エキス、肉エキス、トリ
プトン、ペプトンなど、無機塩としては塩化ナトリウ
ム、塩化マグネシウム、硫酸マグネシウム、塩化カルシ
ウムなどを用いればよい。培養条件としては例えばpH
6.5〜7.5、培養温度は25〜37℃で目的とする
酵素が最高力価となる培養時間、例えば18〜30時間
にて目的となる酵素を採取すればよい。
Next, in obtaining 1,5AG6PDH, preferably Escherichia coli DH1 (ATCC3
3849), and the culture means may be solid culture or liquid culture, but is preferably aeration culture using a flask, a jar or the like. As the medium, those commonly used for culturing microorganisms are widely used. As a carbon source, glucose, glycerol, sorbitol, lactose, etc., as a nitrogen source, yeast extract, meat extract, tryptone, peptone, etc., and as an inorganic salt, sodium chloride, magnesium chloride, magnesium sulfate, calcium chloride, etc. may be used. Culture conditions include, for example, pH
The target enzyme may be collected at 6.5 to 7.5 at a culture temperature of 25 to 37 ° C. and a culture time at which the target enzyme has the highest titer, for example, 18 to 30 hours.

【0020】1,5AG6PDHは主としてその菌体内
に含有、蓄積されており、その菌体内から抽出すればよ
い。1,5AG6PDHの抽出法を例示すれば培養液か
ら菌体を遠心分離などによって分離し、菌体をリン酸緩
衝液、トリス塩酸緩衝液などの緩衝液に懸濁した後、リ
ゾチーム、超音波、ガラスビーズなどによって破砕して
遠心分離し、可溶性画分を粗酵素液として回収する。
1,5AG6PDH is mainly contained and accumulated in the cells, and may be extracted from the cells. If the extraction method of 1,5AG6PDH is exemplified, the cells are separated from the culture solution by centrifugation, and the cells are suspended in a buffer such as a phosphate buffer or a Tris-HCl buffer, and then lysozyme, ultrasound, Crushed by glass beads or the like and centrifuged, and the soluble fraction is collected as a crude enzyme solution.

【0021】このようにして得られた粗製の1,5AG
6PDH含有液を公知の蛋白質、酵素の単離、精製手段
を用いて処理することにより、精製された1,5AG6
PDHを得ることができる。例えばアセトンまたはエタ
ノールなどの有機溶媒による分別沈殿法、硫酸アンモニ
ウムなどによる塩析法、イオン交換クロマトグラフィー
法、疎水クロマトグラフィー法、アフィニティークロマ
トグラフィー法、ゲルろ過法などの一般的な酵素精製法
を適宜選択、組み合わせて精製1,5AG6PDHを得
ることができ、適宜安定化剤例えばショ糖、グリセロー
ルなどを5〜50%程度、アミノ酸、補酵素などを0.
01〜0.1%程度加えて凍結保存または凍結乾燥させ
てもよい。
The thus obtained crude 1,5AG
By treating the 6PDH-containing solution using known protein and enzyme isolation and purification means, the purified 1,5AG6
PDH can be obtained. For example, a general enzyme purification method such as a fractional precipitation method using an organic solvent such as acetone or ethanol, a salting out method using ammonium sulfate, an ion exchange chromatography method, a hydrophobic chromatography method, an affinity chromatography method, and a gel filtration method is appropriately selected. Can be combined with each other to obtain purified 1,5AG6PDH, and about 5 to 50% of an appropriate stabilizer such as sucrose, glycerol, etc., and 0.1% of an amino acid, a coenzyme or the like.
It may be cryopreserved or lyophilized by adding about 01 to 0.1%.

【0022】ADP−HKの1,5AGを基質としたと
きの反応生成物は1,5AG6PDHが作用することか
ら1,5アンヒドログルシトール6リン酸と判明し、
1,5AGを基質として用いた場合の反応式は
When 1,5AG of ADP-HK was used as a substrate, the reaction product was found to be 1,5 anhydroglucitol hexaphosphate because of the action of 1,5AG6PDH.
The reaction formula when 1,5AG is used as a substrate is

【0023】[0023]

【化4】 Embedded image

【0024】で示される。つぎに本発明のADP−HK
の理化学的性質および酵素活性測定法を述べる。 ADP−HKの酵素活性測定法 測定試薬 50mM トリス−塩酸緩衝液(pH7.5) 20mM グルコース 2mM ADP 2mM MgCl2 5U/ml グルコース6リン酸デヒドロゲナーゼ (G6PDH、東洋紡社製) 0.025% NBT 1mM NADP 1% トリトンX−100 5U/ml ジアホラーゼ(NADPH) 測定試薬1mlを37℃で1分間予備加温した後、0.
02mlの酵素液を添加して10分間反応させる。反応
後、0.1N塩酸を2ml添加して反応を停止させ、5
分以内に層長1.0cmのセルを用いて、波長550n
mにおける吸光度を測定する(As)。また盲検として
酵素液のかわりに蒸留水0.02mlを用いて同一の操
作を行って吸光度を測定する(Ab)、この酵素使用の
吸光度(As)と盲検の吸光度(Ab)の吸光度差(A
s−Ab)より酵素活性を求める。酵素活性1単位は3
7℃で1分間に1μモルの還元型NADPを生成させる
酵素量とし、計算式は下記の通りである。 酵素活性(U/ml)=(As−Ab)×0.795×
酵素の希釈倍率 ADP−HKの理化学的性質 (1)酵素作用 基質としてグルコースを用いた場合の酵素作用を以下に
示す。
## EQU1 ## Next, the ADP-HK of the present invention
The method for measuring the physicochemical properties and enzyme activity of is described. ADP-HK Enzyme Activity Assay Measuring Reagent 50 mM Tris-HCl buffer (pH 7.5) 20 mM Glucose 2 mM ADP 2 mM MgCl 2 5 U / ml glucose 6-phosphate dehydrogenase (G6PDH, manufactured by Toyobo) 0.025% NBT 1 mM NADP 1% Triton X-100 5 U / ml diaphorase (NADPH) After preliminarily heating 1 ml of the measurement reagent at 37 ° C. for 1 minute, 0.
Add 02 ml of enzyme solution and react for 10 minutes. After the reaction, the reaction was stopped by adding 2 ml of 0.1N hydrochloric acid, and
Using a cell with a layer length of 1.0 cm within a
The absorbance at m is measured (As). As a blind test, the same operation is performed using 0.02 ml of distilled water instead of the enzyme solution, and the absorbance is measured (Ab). The absorbance difference between the absorbance of the enzyme (As) and the absorbance of the blind test (Ab) (A
The enzyme activity is determined from s-Ab). One unit of enzyme activity is 3
The amount of the enzyme that generates 1 μmol of reduced NADP per minute at 7 ° C. is defined as the amount of the enzyme, and the calculation formula is as follows. Enzyme activity (U / ml) = (As-Ab) × 0.795 ×
Enzyme dilution ratio Physicochemical properties of ADP-HK (1) Enzymatic action Enzymatic action when glucose is used as a substrate is shown below.

【0025】[0025]

【化5】 Embedded image

【0026】(2)基質特異性 基質特異性はADP、MgCl2 の存在下、各基質をA
DP−HKと反応させた後、ADPの変化量をショウデ
ックス・アサヒパック(Showdex Asahip
ak)GS−320HQカラム(昭和電気工業社製)を
用いたHPLC法にて測定した。その結果を表1に示
す。表1より本発明ADP−HKは1,5AGに対して
最も高い基質特異性を示した。
(2) Substrate specificity Substrate specificity is determined by using each substrate in the presence of ADP and MgCl 2.
After reacting with DP-HK, the amount of change in ADP was measured using Showdex Asahippak.
ak) It was measured by an HPLC method using a GS-320HQ column (manufactured by Showa Denki Kogyo KK). Table 1 shows the results. From Table 1, the ADP-HK of the present invention showed the highest substrate specificity for 1,5AG.

【0027】[0027]

【表1】 [Table 1]

【0028】A:バチルス・ステアロサーモフィルス由
来グルコキナーゼ(ファルマシア社製) B:酵母由来ヘキソキナーゼ(オリエンタル酵母工業社
製) C:パイロコッカス・フリオサス由来ADP−HK(特
願平7−340482号公報) (3)等電点 4.1±0.5(pH3.5〜10のキャリアー・アン
ホラインを用いた電気泳動法にて) (4)分子量 50000±5000(TSK−G3000SWXLを用
いたゲルろ過にて) (5)至適pH pH4.0〜5.0は酢酸緩衝液(○−○)、pH5.
0〜6.5はクエン酸緩衝液(△−△)、pH6.5〜
7.5はリン酸緩衝液(□−□)、pH7.5〜8.5
はトリス−塩酸緩衝液(●−●)、pH8.5〜10.
5はグリシン−NaOH緩衝液(▲−▲)を用いた。至
適pHの検討結果を図1に示す。図1より至適pHは7
〜7.5付近にあった。 (6)pH安定性 pH4.0〜5.0は酢酸緩衝液(○−○)、pH5.
0〜6.5はクエン酸緩衝液(△−△)、pH6.5〜
7.5はリン酸緩衝液(□−□)、pH7.5〜8.5
はトリス−塩酸緩衝液(●−●)、pH8.5〜10.
5はグリシン−NaOH緩衝液(▲−▲)を用いた。3
7℃、60分間処理でのpH安定性の検討結果を図2に
示した。図2よりpH6.5〜10.5の範囲で最も良
好な安定性を示した。 (7)至適温度 至適温度の検討結果を図3に示した。図3より至適温度
は80〜100℃であった。 (8)熱安定性 100mMトリス−塩酸緩衝液(pH7.5)(ADP
−HK0.5U/ml)を各温度で10分間熱処理した
後の残存活性を測定した結果、80%以上の残存活性か
ら少なくとも95℃まで安定であった(図4)。 (9)2価の金属イオンの影響 マグネシウムイオンの代わりに各種2価の金属イオンを
添加して、酵素活性を測定し、その結果を表2に示し
た。表2より本発明ADP−HKはマグネシウムイオン
によって最も活性化され、銅イオンにより阻害を受け
た。
A: Bacillus stearothermophilus-derived glucokinase (manufactured by Pharmacia) B: Yeast-derived hexokinase (manufactured by Oriental Yeast Co., Ltd.) C: Pyrococcus furiosus-derived ADP-HK (Japanese Patent Application No. 7-340482) (3) Isoelectric point 4.1 ± 0.5 (by electrophoresis using carrier ampholine at pH 3.5 to 10) (4) Molecular weight 50,000 ± 5000 (gel filtration using TSK-G3000SW XL ) (5) Optimum pH pH 4.0 to 5.0 is acetate buffer (○-○), pH 5.0.
0-6.5 is citrate buffer (△-△), pH 6.5-
7.5 is a phosphate buffer solution (□-□), pH 7.5 to 8.5
Is Tris-HCl buffer (●-●), pH 8.5-10.
5 used a glycine-NaOH buffer (▲-▲). FIG. 1 shows the examination results of the optimum pH. From Fig. 1, the optimum pH is 7
~ 7.5. (6) pH stability pH 4.0 to 5.0 is acetate buffer (液-○), pH 5.0.
0-6.5 is citrate buffer (△-△), pH 6.5-
7.5 is a phosphate buffer solution (□-□), pH 7.5 to 8.5
Is Tris-HCl buffer (●-●), pH 8.5-10.
5 used a glycine-NaOH buffer (▲-▲). 3
FIG. 2 shows the examination results of the pH stability after the treatment at 7 ° C. for 60 minutes. From FIG. 2, the best stability was exhibited in the pH range of 6.5 to 10.5. (7) Optimum temperature FIG. 3 shows the results of the examination of the optimum temperature. 3, the optimum temperature was 80 to 100 ° C. (8) Thermal stability 100 mM Tris-HCl buffer (pH 7.5) (ADP
-HK 0.5 U / ml) after heat treatment at each temperature for 10 minutes. As a result, the residual activity was stable from 80% or more to at least 95 ° C. (FIG. 4). (9) Influence of divalent metal ions In place of magnesium ions, various divalent metal ions were added, and the enzymatic activities were measured. The results are shown in Table 2. From Table 2, the ADP-HK of the present invention was most activated by magnesium ions and inhibited by copper ions.

【0029】[0029]

【表2】 [Table 2]

【0030】(10)各種添加物の影響 活性測定法(MgCl2 を2mM含有)に基づき、その
他の金属イオンおよび界面活性剤などの各種添加物の影
響を表3に示した。表3より本発明ADP−HKはED
TAにより阻害を受けた。
(10) Influence of various additives Table 3 shows the influence of various additives such as other metal ions and surfactants based on the activity measurement method (containing 2 mM MgCl 2 ). According to Table 3, the ADP-HK of the present invention is ED
Inhibited by TA.

【0031】[0031]

【表3】 [Table 3]

【0032】(11)ヌクレオシドジリン酸類に対する
作用 ヌクレオシドジリン酸類としてADP、GDP、CD
P、UDPおよびIDPを用いて活性測定を行った結果
を表4に示す。表4より本発明ADP−HKはADPお
よびCDPに対して高い特異性を示した。
(11) Action on nucleoside diphosphates ADP, GDP, CD as nucleoside diphosphates
Table 4 shows the results of activity measurement using P, UDP and IDP. From Table 4, the ADP-HK of the present invention showed high specificity for ADP and CDP.

【0033】[0033]

【表4】 [Table 4]

【0034】[0034]

【発明の実施の形態】次いで、本発明について実施例お
よび参考例を挙げて詳細に述べるが、本発明は何らこれ
らに限定されるものではない。
Next, the present invention will be described in detail with reference to examples and reference examples, but the present invention is not limited to these examples.

【0035】[0035]

【参考例1】 1,5AG6PDH生産菌の培養 エシェリヒア・コリ・DH1(ATCC33849)の
培養 培地組成 0.5% 肉エキス 1.5% ソルビトール 1.0% トリプトン 1.5% ビール酵母エキス 上記培地成分を含む液体培地(pH7.5)50mlを
300ml容三角フラスコ2本に分注し、120℃、2
0分間、加熱滅菌した後、これにエシェリヒア.コリD
H1(ATCC33849)の菌体懸濁液1mlを移植
し、攪拌させながら、30℃で15時間培養し、種培養
液とした。上記培地成分と消泡剤FSアンチフォーム0
28(ダウコーニング社製)を0.3%含む液体培地5
lを10l容ジャー2ヶにおいて滅菌した後に種培養液
を移植し、37℃で培養液のpHを5NのNaOHで
6.5以上になるよう制御して好気的に撹拌しながら2
4時間培養し、培養力価15mU/mlの培養液10l
を得た。
[Reference Example 1] Culture of 1,5AG6PDH-producing bacteria Culture of Escherichia coli / DH1 (ATCC33849) Medium composition 0.5% Meat extract 1.5% Sorbitol 1.0% Tryptone 1.5% Beer yeast extract 50 ml of a liquid medium (pH 7.5) containing the mixture is dispensed into two 300 ml Erlenmeyer flasks.
After heat sterilization for 0 minutes, Escherichia. Coli D
1 ml of a cell suspension of H1 (ATCC 33849) was transplanted and cultured at 30 ° C. for 15 hours while stirring to obtain a seed culture solution. The above medium components and antifoam FS Antifoam 0
Liquid medium 5 containing 0.3% 28 (manufactured by Dow Corning)
After sterilizing the mixture in two 10-liter jars, the seed culture was transplanted, and the pH of the culture was controlled at 37 ° C. with 5N NaOH to be 6.5 or more while aerobically stirring.
After culturing for 4 hours, 10 l of a culture solution having a culture titer of 15 mU / ml
I got

【0036】1,5AG6PDHの精製 得られた培養液10lを遠心分離して、得られた菌体を
50mMのトリス−塩酸緩衝液(pH8.5)で1回洗
浄した。洗浄菌体を50mMのトリス−塩酸緩衝液(p
H8.5)に懸濁して1.2lに調整し、DYNO−M
ILL(Willy・A.Bachofen社製)を用
いて菌体破砕を行い、菌体破砕液を得た。
Purification of 1,5AG6PDH 10 l of the obtained culture was centrifuged, and the obtained cells were washed once with 50 mM Tris-HCl buffer (pH 8.5). The washed cells were washed with 50 mM Tris-HCl buffer (p.
H8.5), adjusted to 1.2 l, and DYNO-M
The cells were disrupted using ILL (manufactured by Willy A. Bachofen) to obtain a disrupted cell suspension.

【0037】この破砕液を透析チューブを用いて50m
Mのトリス−塩酸緩衝液(pH8.5)20lに対して
5℃で一夜透析した後、8000rpm、60分間遠心
分離し、1.0l(酵素活性120U)の上清を得た。
この上清を50mMのトリス−塩酸緩衝液(pH8.
5)で緩衝化したDEAE−Sepharose・FF
(ファルマシア社製)1200ml(2.6×38c
m)のカラムに通し、0〜0.25MのNaClのリニ
アグラジエントで溶出を行った。その結果、約0.15
MのNaCl濃度で活性画分(75U)が溶出された。
この得られた活性画分に3MとなるようにNaClを溶
解し、50mMのトリス−塩酸緩衝液(pH8.5),
3MのNaClで平衝化されたPhenyl−Seph
arose・CL4B(ファルマシア社製)500ml
(2.6×38cm)のカラムに通し、2.5〜0Mの
NaClのリニアグラジエントにより溶出を行った。そ
の結果、約1.2MのNaCl濃度で活性画分(50
U)が得られた。この得られた活性画分を20mMのト
リス−塩酸緩衝液(pH8.5)で、一夜透析した後、
20mMのトリス−塩酸緩衝液(pH8.5)で緩衝化
したBlue−sepharose(ファルマシア社
製)50ml(2.6×19cm)のカラムに通し、0
〜1MのNaCl,20%エチレングリコールのリニア
グラジエントにより溶出を行った。その結果、約0.6
MのNaCl、12%エチレングリコールの濃度で活性
画分(30U)が溶出された。この得られた活性画分を
50mMトリス−塩酸緩衝液(pH8.5)で一夜透析
した後、50mMトリス−塩酸緩衝液(pH8.5)で
緩衝化したResource・Q(ファルマシア社製)
6mlのカラムに通し、0〜0.3MのNaClのリニ
アグラジエントにより溶出を行った。その結果、約0.
15MのNaCl濃度で活性画分(28U)が得られ、
均質な酵素標品を得た。
This crushed liquid was subjected to 50 m
After dialyzing overnight at 5 ° C. against 20 l of M Tris-HCl buffer (pH 8.5), the mixture was centrifuged at 8000 rpm for 60 minutes to obtain 1.0 l (enzyme activity: 120 U) of supernatant.
This supernatant was treated with 50 mM Tris-HCl buffer (pH 8.
DEAE-Sepharose FF buffered in 5)
(Pharmacia) 1200ml (2.6 x 38c
The column was eluted with a linear gradient of 0 to 0.25 M NaCl. As a result, about 0.15
An active fraction (75 U) was eluted at an M NaCl concentration.
NaCl was dissolved in the obtained active fraction to a concentration of 3 M, and a 50 mM Tris-HCl buffer (pH 8.5),
Phenyl-Seph equilibrated with 3M NaCl
arose CL4B (Pharmacia) 500ml
It was passed through a (2.6 × 38 cm) column and eluted with a linear gradient of 2.5 to 0 M NaCl. As a result, the active fraction (50
U) was obtained. The obtained active fraction was dialyzed overnight against 20 mM Tris-HCl buffer (pH 8.5),
After passing through a 50 ml (2.6 × 19 cm) column of Blue-sepharose (Pharmacia) buffered with 20 mM Tris-HCl buffer (pH 8.5),
Elution was performed with a linear gradient of 11 M NaCl, 20% ethylene glycol. As a result, about 0.6
An active fraction (30 U) was eluted at a concentration of M NaCl and 12% ethylene glycol. The obtained active fraction was dialyzed overnight against 50 mM Tris-HCl buffer (pH 8.5), and then buffered with 50 mM Tris-HCl buffer (pH 8.5) Resource Q (Pharmacia).
Elution was performed with a linear gradient of 0-0.3 M NaCl through a 6 ml column. As a result, about 0.
An active fraction (28 U) was obtained at a NaCl concentration of 15 M,
A homogeneous enzyme preparation was obtained.

【0038】1,5AG6PDHの理化学的性質 (1)作用 1,5AG6PDHを補酵素の存在下脱水素し、組成式
(C6 118 1 )の化合物とする下記の反応式
Physicochemical properties of 1,5AG6PDH (1) Action 1,5AG6PDH is dehydrogenated in the presence of a coenzyme to give a compound of the formula (C 6 H 11 O 8 P 1 )

【0039】[0039]

【化6】 Embedded image

【0040】で表される反応を触媒する。 (2)力価の測定法 1,5AG6PDHの酵素活性測定法 測定試薬 50mM CAPS−NaOH緩衝液(pH10.0) 1mM NADP 5mM 1,5AG6P (CAPS:N−Cyclohexyl−3−aminopropanesu− lfonic acid) 測定試薬1mlを光路長1cmのセルに入れ37℃で5
分間予備加温した後、0.01mlの酵素液添加後0.
5分後の波長340nmにおける吸光度(Aa)と酵素
液添加後1.5分後の吸光度(Ab)を測定する。この
吸光度(Aa)と(Ab)の吸光度差(Ab−Aa)よ
り酵素活性を求める。なお、吸光度(Ab)が0.2以
上になる時は酵素液を50mM CAPS−NaOH緩
衝液(pH10.0)で希釈して測定するものとする。
酵素活性1単位は37℃で1分間に1μモルの還元型N
ADPを生成させる酵素量とし、計算式は下記の通りで
ある。 酵素活性(U/ml)=(Ab−Aa)×13.5×酵
素の希釈倍率 (3)基質特異性 上記力価測定法を利用して、その反応液中の1,5AG
6Pの代わりに、種々の基質を用いて、1,5AG6P
に対する相対活性を求めた結果を表5に示す。その結
果、この酵素は少なくとも1,5AG6Pに基質特異性
を示した。
Catalyze the reaction represented by (2) Measuring method of titer Measuring method of enzyme activity of 1,5AG6PDH Measuring reagent 50 mM CAPS-NaOH buffer (pH 10.0) 1 mM NADP 5 mM 1,5AG6P (CAPS: N-Cyclohexyl-3-aminopropanesu-sulfonic acid) Measurement 1 ml of the reagent is placed in a cell having an optical path length of 1 cm,
After preliminarily heating for 0.01 minute, add 0.01 ml of enzyme solution and
The absorbance (Aa) at a wavelength of 340 nm after 5 minutes and the absorbance (Ab) 1.5 minutes after addition of the enzyme solution are measured. The enzyme activity is determined from the absorbance difference (Ab-Aa) between the absorbances (Aa) and (Ab). When the absorbance (Ab) becomes 0.2 or more, the enzyme solution is diluted with 50 mM CAPS-NaOH buffer (pH 10.0) for measurement.
One unit of enzyme activity is 1 μmol of reduced N per minute at 37 ° C.
The amount of the enzyme that generates ADP is calculated by the following formula. Enzyme activity (U / ml) = (Ab-Aa) x 13.5 x dilution ratio of enzyme (3) Substrate specificity Using the above titration method, 1,5AG in the reaction solution was used.
Instead of 6P, using various substrates, 1,5AG6P
Table 5 shows the results of the determination of the relative activity to As a result, this enzyme showed substrate specificity for at least 1,5AG6P.

【0041】[0041]

【表5】 [Table 5]

【0042】(3)至適pH pH7.0〜9.0はトリス塩酸緩衝液(□−□)、p
H9.5〜10.5はCAPS−NaOH緩衝液(■−
■)を用いた。至適pHは9〜10付近であり、結果を
図5に示した。 (4)pH安定性 pH4.0〜5.5はクエン酸緩衝液(○−○)、pH
5.5〜7.0はビストリス塩酸緩衝液(●−●)、p
H7.0〜9.0はトリス塩酸緩衝液(□−□)、pH
9.5〜11.0はCAPS−NaOH緩衝液(■−
■)を用いた。50℃、30分処理でpH6〜9におい
て安定であり、結果を図6に示した。
(3) Optimum pH pH 7.0 to 9.0 is determined using Tris-HCl buffer (□-□), p
H9.5 to 10.5 is a CAPS-NaOH buffer (■-
(2) was used. The optimum pH was around 9 to 10, and the results are shown in FIG. (4) pH stability pH 4.0 to 5.5 is citrate buffer (液-○), pH
5.5-7.0 are bistris-HCl buffers (●-●), p
H7.0-9.0 are Tris-HCl buffer (□-□), pH
9.5 to 11.0 is a CAPS-NaOH buffer solution (■-
(2) was used. It was stable at pH 6 to 9 after treatment at 50 ° C. for 30 minutes, and the results are shown in FIG.

【0043】(5)至適温度 上記の力価測定法における測定法を利用して、その温度
条件を変えて酵素反応を行った結果は図7に示す通りで
あって、その至適温度は37〜50℃であった。 (6)熱安定性 1,5AG6PDHを1U/mlを含有して成る50m
M CAPS−NaOH緩衝液(pH9.5)を各温度
に30分間放置し、ついで上記の力価測定法に従って、
1,5AG6PDHの残存活性を測定した結果、図8に
示す通りであって、酵素は45℃付近までは安定であっ
た。
(5) Optimum temperature The results of enzymatic reaction performed by changing the temperature conditions using the measuring method in the above titration method are as shown in FIG. 37-50 ° C. (6) Thermal stability 50 m comprising 1 U / ml of 1,5AG6PDH
The MCAPS-NaOH buffer (pH 9.5) was left at each temperature for 30 minutes and then according to the titration method described above.
As a result of measuring the residual activity of 1,5AG6PDH, as shown in FIG. 8, the enzyme was stable up to around 45 ° C.

【0044】(7)種々の物質による影響 上記の力価測定法において、種々の添加物を加えて、
1,5AG6PDHの1,5AG6Pに対する酵素活性
を測定した結果を表6に示す。
(7) Influence by various substances In the above titration method, various additives were added.
Table 6 shows the results of measurement of the enzyme activity of 1,5AG6PDH against 1,5AG6P.

【0045】[0045]

【表6】 [Table 6]

【0046】(8)分子量 78000±6000(TSKgel・G3000SW
XL(東ソー社製)を用いたゲル濾過法による) (9)等電点 4.7±0.5(キャリアアンフォライトpH3.5−
pH10(ファルマシア製)を用いる電気泳動法により
測定) (10)Km値 1,5AG6Pに対するKm値:25mM NADPに対するKm値:0.09mM (11)作用機序確認試験 1,5AG6P、NADP、トリエチルアミン重炭酸緩
衝液(pH10.0)、1,5AG6PDHを含む反応
液を37℃、8時間反応せしめる。1,5AG6Pに生
成したカルボニル基を2,4−ジニトロフェニルヒドラ
ジンとHClを加えて反応せしめヒドラゾンとして分離
し、マススペクトルを測定することで生成物が組成式
(C6 118 1 )で表されるものであることが確認
された。
(8) Molecular weight 78,000 ± 6000 (TSKgel.G3000SW)
(By gel filtration method using XL (manufactured by Tosoh Corporation)) (9) Isoelectric point 4.7 ± 0.5 (carrier ampholite pH 3.5-
(Measured by electrophoresis using pH 10 (manufactured by Pharmacia)) (10) Km value: Km value for 1,5AG6P: 25 mM Km value for NADP: 0.09 mM (11) Mechanism of action confirmation test 1,5AG6P, NADP, triethylamine weight A reaction solution containing a carbonate buffer (pH 10.0) and 1,5AG6PDH is reacted at 37 ° C. for 8 hours. The carbonyl group generated in 1,5AG6P was reacted with 2,4-dinitrophenylhydrazine and HCl and separated as a hydrazone, and the mass spectrum was measured to find that the product had the composition formula (C 6 H 11 O 8 P 1 ) Was confirmed.

【0047】[0047]

【実施例1】サーモコッカス・リトラリス(Therm
ococcus・litoralis)ATCC518
50菌株の培養 培地組成 0.1% 酵母エキス 0.5% トリプトン 0.72% マルトース 2.39% NaCl 0.4% Na2 SO4 0.07% KCl 0.02% NaHCO3 0.01% KBr 0.03% H3 BO4 1.08% MgCl2 0.15% CaCl2 0.0025% SrCl2 0.025% NH4 Cl 0.014% K2 HPO4 0.1% CH3 COONa 0.0015% N(COOH)3 0.0005% MnSO4 0.0014% FeSO4 0.0002% NiCl2 0.0001% CoSO4 0.0001% ZnSO4 0.00001% CuSO4 0.000001% Na2 Wo4 0.000001% Na2 Mo4 0.1% システイン塩酸塩 上記培地成分を含む液体培地(pH7)500mlを5
00ml溶三角フラスコ1本に分注し、120℃、20
分間、加熱滅菌した後、これにサーモコッカス・リトラ
リス・ATCC51850株の菌体懸濁液10mlを移
植し、攪拌させながら、95℃で20時間培養し、種培
養液とした。上記培地成分を含む液体培地20l/30
lジャーを滅菌した後、種培養液を移植し、緩やかに攪
拌させながら、95℃で15時間培養し、5mU/ml
の培養液20lを得た。
Example 1 Thermococcus litoralis (Therm
ococcus litoralis) ATCC518
50 0.5% culture medium composition of 0.1% yeast extract strains tryptone 0.72% maltose 2.39% NaCl 0.4% Na 2 SO 4 0.07% KCl 0.02% NaHCO 3 0.01% KBr 0.03% H 3 BO 4 1.08% MgCl 2 0.15% CaCl 2 0.0025% SrCl 2 0.025% NH 4 Cl 0.014% K 2 HPO 4 0.1% CH 3 COONa 0 0.0015% N (COOH) 3 0.0005% MnSO 4 0.0014% FeSO 4 0.0002% NiCl 2 0.0001% CoSO 4 0.0001% ZnSO 4 0.00001% CuSO 4 0.000001% Na 2 Wo 4 0.000001% Na 2 Mo 4 0.1% cysteine hydrochloride 500 ml of a liquid medium (pH 7) containing the above medium components
Dispense into a single 00 ml Erlenmeyer flask,
After heat sterilization for 10 minutes, 10 ml of a cell suspension of Thermococcus litoralis ATCC 51850 strain was transplanted into this, and cultured at 95 ° C. for 20 hours with stirring to obtain a seed culture solution. 20 l / 30 liquid medium containing the above medium components
After sterilizing the jar, the seed culture is transplanted and cultured at 95 ° C. for 15 hours while gently stirring, and 5 mU / ml
Of the culture was obtained.

【0048】[0048]

【実施例2】 ADP−HKの精製 得られた培養液20lを遠心分離して、得られた菌体を
0.9%のNaClを含む20mMのトリス−塩酸緩衝
液(pH7.5)で1回洗浄した。洗浄菌体を20mM
のトリス−塩酸緩衝液(pH7.5)に懸濁して220
mlに調整し、クボタ社製の超音波破砕機(INSON
ATOR 201M)を用いて180W、30分間処理
して、菌体破砕液を得た。
Example 2 Purification of ADP-HK Twenty liters of the obtained culture was centrifuged, and the obtained cells were treated with 20 mM Tris-HCl buffer (pH 7.5) containing 0.9% NaCl. Washed twice. 20 mM washed cells
Suspended in Tris-HCl buffer (pH 7.5).
ml, and an ultrasonic crusher manufactured by Kubota (INSON
(ATOR 201M) at 180 W for 30 minutes to obtain a disrupted cell suspension.

【0049】この破砕液を8000rpm、30分間遠
心分離し、210ml(酵素活性122U)の上清を得
た。この上清を透析チューブを用いて10mMのトリス
−塩酸緩衝液(pH7.5)8lに対して5℃で一夜透
析した後、10mMのトリス−塩酸緩衝液(pH7.
5)で緩衝化したDEAE−Sepharose FF
(ファルマシア社製)200ml(2.6×38cm)
のカラムに通し、0〜1モルのNaClのリニアグラジ
エントで溶出を行った。その結果、0.65〜0.7モ
ルのNaCl濃度で活性画分(96U)が溶出された。
この得られた活性画分に4MとなるようにNaClを溶
解し、4MのNaClで緩衝化されたPhenyl−S
epharose FF(ファルマシア社製)200m
l(2.6×38cm)のカラムに通し、4〜0MのN
aClのリニアグラジエントにより溶出を行った。その
結果、0.02〜0.07モルのNaCl濃度で活性画
分(70)が得られた。この得られた活性画分を10m
Mトリス−塩酸(pH7.5)8lに5℃、一夜透析し
た後、10mMトリス−塩酸緩衝液(pH7.5)で緩
衝化したヒドロキシアパタイト(ペンタックス社製)1
00ml(2.6×19cm)のカラムに通し、0〜
0.5Mのリン酸緩衝液(pH7.5)のリニアグラジ
エントにより溶出を行った。その結果、0.02〜0.
03Mのリン酸緩衝液濃度で活性画分(60U)が溶出
され、均質な酵素標品を得た。
This crushed liquid was centrifuged at 8000 rpm for 30 minutes to obtain 210 ml (enzyme activity: 122 U) of a supernatant. The supernatant was dialyzed overnight at 5 ° C. against 8 liters of 10 mM Tris-HCl buffer (pH 7.5) using a dialysis tube, and then 10 mM Tris-HCl buffer (pH 7.0).
DEAE-Sepharose FF buffered in 5)
(Pharmacia) 200ml (2.6 × 38cm)
And elution was performed with a linear gradient of 0 to 1 mol of NaCl. As a result, an active fraction (96 U) was eluted at a NaCl concentration of 0.65 to 0.7 mol.
NaCl was dissolved to 4 M in the obtained active fraction, and Phenyl-S buffered with 4 M NaCl was used.
epharose FF (Pharmacia) 200m
1 (2.6 × 38 cm) column, 4 to 0 M N
Elution was performed with a linear gradient of aCl. As a result, an active fraction (70) was obtained at a NaCl concentration of 0.02 to 0.07 mol. The obtained active fraction is 10 m
After dialysis overnight at 5 ° C. against 8 l of M Tris-hydrochloric acid (pH 7.5), hydroxyapatite (Pentax) 1 buffered with 10 mM Tris-hydrochloric acid buffer (pH 7.5) 1
Pass through a 00 ml (2.6 × 19 cm) column,
Elution was performed with a linear gradient of 0.5 M phosphate buffer (pH 7.5). As a result, 0.02-0.
The active fraction (60 U) was eluted at a phosphate buffer concentration of 03 M to obtain a homogeneous enzyme preparation.

【0050】[0050]

【発明の効果】1,5AGに対して高い基質特異性を有
し、1,5AGの簡便かつ高精度の測定に用いることの
できる新規なADP−HKを提供できた。
According to the present invention, a novel ADP-HK having a high substrate specificity to 1,5AG and capable of being used for simple and accurate measurement of 1,5AG can be provided.

【図面の簡単な説明】[Brief description of the drawings]

【図1】図1は本発明ADP−HKの至適pH曲線を示
す。
FIG. 1 shows an optimal pH curve of ADP-HK of the present invention.

【図2】図2は本発明ADP−HKのpH安定性曲線を
示す。
FIG. 2 shows a pH stability curve of ADP-HK of the present invention.

【図3】図3は本発明ADP−HKの至適温度曲線を示
す。
FIG. 3 shows an optimal temperature curve of ADP-HK of the present invention.

【図4】図4は本発明ADP−HKの熱安定性曲線を示
す。
FIG. 4 shows a thermal stability curve of ADP-HK of the present invention.

【図5】図5は1,5AG6PDHの至適pH曲線を示
す。
FIG. 5 shows an optimum pH curve of 1,5AG6PDH.

【図6】図6は1,5AG6PDHのpH安定性曲線を
示す。
FIG. 6 shows a pH stability curve of 1,5AG6PDH.

【図7】図7は1,5AG6PDHの至適温度曲線を示
す。
FIG. 7 shows an optimum temperature curve of 1,5AG6PDH.

【図8】図8は1,5AG6PDHの熱安定性曲線を示
す。
FIG. 8 shows a thermal stability curve of 1,5AG6PDH.

【手続補正書】[Procedure amendment]

【提出日】平成9年7月24日[Submission date] July 24, 1997

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0023[Correction target item name] 0023

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0023】[0023]

【化4】 Embedded image

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 基質としてグルコースを用いるに比べて
1,5アンヒドログルシトールに対して高い基質特異性
を有し、ヌクレオシドジリン酸類およびマグネシウムイ
オン存在下1,5アンヒドログルシトールの6位の水酸
基をリン酸基に置換し、1,5アンヒドログルシトール
6リン酸とヌクレオシドモノリン酸類を生成する反応を
触媒するADP依存性ヘキソキナーゼ。
The present invention has a high substrate specificity for 1,5 anhydroglucitol as compared with the case where glucose is used as a substrate, and has a high specificity for 1,5 anhydroglucitol in the presence of nucleoside diphosphates and magnesium ions. ADP-dependent hexokinase that catalyzes the reaction of substituting a hydroxyl group at the 2-position with a phosphate group to generate 1,5 anhydroglucitol hexaphosphate and nucleoside monophosphates.
【請求項2】 ヌクレオシドジリン酸類がADPであ
り、ヌクレオシドモノリン酸類がAMPである請求項1
記載のヘキソキナーゼ。
2. The nucleoside diphosphate is ADP, and the nucleoside monophosphate is AMP.
The hexokinase as described.
【請求項3】 請求項1に属するADP依存性ヘキソキ
ナーゼが、少なくとも下記の理化学的性質を有する。 (1)酵素作用 基質としてグルコース、ヌクレオシドジリン酸としてA
DPを用いた場合の酵素作用を以下に示す。 【化1】 (2)基質特異性 基質としてグルコースを用いるに比べて1,5アンヒド
ログルシトールに対して高い特異性を示す。 (3)等電点 4.1±0.5(pH3.5〜10のキャリアー・アン
ホラインを用いた電気泳動法にて) (4)分子量 50000±5000(TSK−G3000SWXLを用
いたゲルろ過にて) (5)至適pH 至適pHは7〜7.5にあった。 (6)pH安定性 pH6.5〜10.5の範囲で最も良好な安定性を示し
た。 (7)至適温度 至適温度は80〜100℃であった。 (8)熱安定性 100mMトリス−塩酸緩衝液(pH7.5)(ADP
依存性ヘキソキナーゼ0.5U/ml)を各温度で10
分間熱処理した後の残存活性を測定した結果、少なくと
も95℃まで安定であった。
3. The ADP-dependent hexokinase according to claim 1 has at least the following physicochemical properties. (1) Enzyme action Glucose as substrate, A as nucleoside diphosphate
The enzymatic action when DP is used is shown below. Embedded image (2) Substrate specificity Higher specificity for 1,5 anhydroglucitol compared to using glucose as a substrate. (3) Isoelectric point 4.1 ± 0.5 (by electrophoresis using carrier ampholine of pH 3.5 to 10) (4) Molecular weight 50,000 ± 5000 (for gel filtration using TSK-G3000SW XL ) (5) (5) Optimum pH The optimum pH was in the range of 7 to 7.5. (6) pH stability The best stability was exhibited in the pH range of 6.5 to 10.5. (7) Optimum temperature The optimum temperature was 80 to 100 ° C. (8) Thermal stability 100 mM Tris-HCl buffer (pH 7.5) (ADP
Dependent hexokinase (0.5 U / ml) at each temperature
As a result of measuring the residual activity after heat treatment for 5 minutes, it was stable at least up to 95 ° C.
JP12377497A 1997-05-14 1997-05-14 Kinase Expired - Fee Related JP4001658B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12377497A JP4001658B2 (en) 1997-05-14 1997-05-14 Kinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12377497A JP4001658B2 (en) 1997-05-14 1997-05-14 Kinase

Publications (2)

Publication Number Publication Date
JPH10313857A true JPH10313857A (en) 1998-12-02
JP4001658B2 JP4001658B2 (en) 2007-10-31

Family

ID=14868959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12377497A Expired - Fee Related JP4001658B2 (en) 1997-05-14 1997-05-14 Kinase

Country Status (1)

Country Link
JP (1) JP4001658B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008263996A (en) * 2008-06-02 2008-11-06 National Institute Of Advanced Industrial & Technology Method for producing and refining light-emitting beetle-derived red luciferase-stabilized form

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008263996A (en) * 2008-06-02 2008-11-06 National Institute Of Advanced Industrial & Technology Method for producing and refining light-emitting beetle-derived red luciferase-stabilized form

Also Published As

Publication number Publication date
JP4001658B2 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
US5871949A (en) Method of quantitative assay for 1,5-anhydroglucitol and reagent for quantitative assay
EP0477001B1 (en) Highly sensitive assay method for myo-inositol and composition for practicing same
EP0881301B1 (en) Method for assaying vital sample
AU722636B2 (en) Method for quantitative determination of 1,5-anhydroglucitol
Atkinson et al. Permeability of Rickettsia prowazekii to NAD
JP4140929B2 (en) Method for measuring 1,5AG or ADP
JP3049217B2 (en) How to measure ADP
EP0790302B1 (en) Novel hexokinase
JP4001658B2 (en) Kinase
JP4155415B2 (en) Measuring method of biological sample
JP3852991B2 (en) 1,5-Anhydroglucitol-6-phosphate dehydrogenase, process for producing the same and use thereof
US6046018A (en) Highly sensitive method for assaying chiro-inositol and compositions for the assay
JPH10225300A (en) Highly sensitive determination of glucose or adp
EP1099765A1 (en) Quantitative determination method of mannose and reagent therefor
JPH08168375A (en) Pyruvateorthophosphatedikinase and method for producing the same
JP3065754B2 (en) Novel xanthine dehydrogenase-T enzyme, measuring method using the same, and analytical composition containing the enzyme
JP3012356B2 (en) Manufacturing method of fructokinase
JP2827002B2 (en) Method for measuring acylcarnitine
JPH0661278B2 (en) Sensitive method for quantitative determination of myo-inositol and composition for quantitative determination
JP3929576B2 (en) Microorganism producing enzyme acting on phosphorylated 1,5-anhydroglucitol, enzyme produced by the microorganism, and method for quantifying phosphorylated 1,5-anhydroglucitol using the same
JP2886846B2 (en) 1,5-anhydroglucitol dehydrogenase and method for producing the same
JP3190537B2 (en) Method for producing novel maltose 1-epimerase
JP3862034B2 (en) Method for measuring glucose
JP2000093196A (en) Determination of chiroinositol
JPH08168398A (en) Reagent for determining maltose and method for determining the same

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070612

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070712

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070814

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070815

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100824

Year of fee payment: 3

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100824

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110824

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110824

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120824

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130824

Year of fee payment: 6

LAPS Cancellation because of no payment of annual fees